Use of prothrombin complex concentrates for urgent reversal of dabigatran in the Emergency Department

被引：39

作者：

Quintana Diaz, Manuel ^{[1
,2
]}

Borobia, Alberto M. ^{[1
,3
]}

Rivera Nunez, Ma Angelica ^{[1
]}

Martinez Virto, Ana Maria ^{[1
]}

Fabra, Sara ^{[1
]}

Sanchez Casado, Marcelino ^{[4
]}

Garcia-Erce, Jose A. ^{[5
]}

Meyer Samama, C. ^{[5
]}

机构：

[1] Hosp Univ La Paz Madrid, Gen Emergency Dept, IdiPAZ, Madrid, Spain

[2] Hosp Univ La Paz Madrid, IdiPAZ, Intens Care Unit, Madrid, Spain

[3] Univ Autonoma Madrid, Hosp Univ La Paz Madrid, Sch Med, Clin Pharmacol Serv,IdiPAZ, E-28049 Madrid, Spain

[4] Hosp Virgen Salud, Intens Care Unit, Toledo, Spain

[5] Hosp San Jorge Huesca, Haematol Serv, Huesca, Spain

来源：

HAEMATOLOGICA | 2013年 / 98卷 / 11期

关键词：

dabigatran; prothrombin complex concentrate; bleeding; reversal; ATRIAL-FIBRILLATION; ETEXILATE; RIVAROXABAN; ENOXAPARIN; WARFARIN;

D O I：

10.3324/haematol.2013.092767

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E143 / E144

页数：2

共 13 条

[1]

[Anonymous], PRAD MON

[2] Rivaroxaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials [J].

Cao, Yong Bing ;

Zhang, Jun Dong ;

Shen, Hui ;

Jiang, Yuan Ying .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (11) :1099-1108

[3] Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile [J].

Clemens, Andreas ;

van Ryn, Joanne ;

Sennewald, Regina ;

Yamamura, Norio ;

Stangier, Joachim ;

Feuring, Martin ;

Haertter, Sebastian .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (05) :607-616

[4] Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects [J].

Eerenberg, Elise S. ;

Kamphuisen, Pieter W. ;

Sijpkens, Meertien K. ;

Meijers, Joost C. ;

Buller, Harry R. ;

Levi, Marcel .

CIRCULATION, 2011, 124 (14) :1573-1579

[5]

European Medicines Agency, PRAD DAB ET

[6] Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation [J].

Kansal, Anuraag R. ;

Sorensen, Sonja V. ;

Gani, Ray ;

Robinson, Paul ;

Pan, Feng ;

Plumb, Jonathan M. ;

Cowie, Martin R. .

HEART, 2012, 98 (07) :573-578

[7] Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate [J].

Lambourne, M. D. ;

Eltringham-Smith, L. J. ;

Gataiance, S. ;

Arnold, D. M. ;

Crowther, M. A. ;

Sheffield, W. P. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (09) :1830-1840

[8] Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: Implications for emergency surgery and resuscitation [J].

Louet, Agnes Lillo-Le ;

Wolf, Martine ;

Soufir, Lilia ;

Galbois, Arnaud ;

Dumenil, Anne-Sylvie ;

Offenstadt, Georges ;

Samama, Meyer-Michel .

THROMBOSIS AND HAEMOSTASIS, 2012, 108 (03) :583-585

[9] A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation The Euro Head Survey [J].

Pisters, Ron ;

Lane, Deirdre A. ;

Nieuwlaat, Robby ;

de Vos, Cees B. ;

Crijns, Harry J. G. M. ;

Lip, Gregory Y. H. .

CHEST, 2010, 138 (05) :1093-1100

[10] Reversal of dabigatran anticoagulation by prothrombin complex concentrate (Beriplex P/N) in a rabbit model [J].

Pragst, I. ;

Zeitler, S. H. ;

Doerr, B. ;

Kaspereit, F. J. ;

Herzog, E. ;

Dickneite, G. ;

Van Ryn, J. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (09) :1841-1848

← 1 2 →